NovoCure Limited (NVCR)
NASDAQ: NVCR · IEX Real-Time Price · USD
19.02
+0.37 (1.98%)
Jul 26, 2024, 4:00 PM EDT - Market closed
NovoCure Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
---|---|---|---|---|---|---|---|
Net Income | -168.7 | -207.04 | -92.53 | -58.35 | 19.81 | -7.23 | Upgrade
|
Depreciation & Amortization | 9.93 | 9.7 | 9.57 | 9.17 | 7.75 | 6.78 | Upgrade
|
Other Amortization | 4.59 | 4.59 | 4.35 | 4.42 | 5.91 | 1.84 | Upgrade
|
Asset Writedown & Restructuring Costs | 0.57 | 0.49 | 0.96 | 0.65 | 0.43 | 0.4 | Upgrade
|
Loss (Gain) From Sale of Investments | -26.4 | -26.4 | -4.83 | -0.24 | -1.25 | -2.33 | Upgrade
|
Stock-Based Compensation | 109.7 | 115.61 | 106.96 | 94.9 | 75.72 | 52.42 | Upgrade
|
Other Operating Activities | -1.34 | 0.07 | -5.47 | 3.14 | -0.7 | -0.92 | Upgrade
|
Change in Accounts Receivable | -6.43 | 29.41 | 2.55 | 5.27 | -30.35 | -36.5 | Upgrade
|
Change in Inventory | -7.51 | -8.92 | -4.34 | 2.48 | -2.94 | -1.16 | Upgrade
|
Change in Accounts Payable | 16.43 | 14.87 | 14.26 | 27.78 | 25.47 | 16.88 | Upgrade
|
Change in Other Net Operating Assets | 2.01 | -5.71 | -0.67 | -6.46 | -0.7 | -3.56 | Upgrade
|
Operating Cash Flow | -67.17 | -73.34 | 30.79 | 82.76 | 99.15 | 26.62 | Upgrade
|
Operating Cash Flow Growth | - | - | -62.80% | -16.53% | 272.46% | - | Upgrade
|
Capital Expenditures | -37.3 | -27.09 | -21.36 | -24.17 | -14.97 | -10.49 | Upgrade
|
Investment in Securities | 24.84 | 211.24 | -118.6 | -120.66 | -457.88 | -41.18 | Upgrade
|
Investing Cash Flow | -12.47 | 184.15 | -139.96 | -144.83 | -472.85 | -51.67 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 558.44 | - | Upgrade
|
Total Debt Issued | 96.92 | - | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -0.01 | -0.03 | -0.03 | -150.03 | -0.03 | Upgrade
|
Total Debt Repaid | -12.91 | - | - | - | - | - | Upgrade
|
Net Debt Issued (Repaid) | 84.01 | -0.01 | -0.03 | -0.03 | 408.41 | -0.03 | Upgrade
|
Issuance of Common Stock | 6.6 | 15.8 | 15.52 | 25.73 | 31.8 | 61.71 | Upgrade
|
Financing Cash Flow | 90.61 | 15.79 | 15.49 | 25.7 | 440.21 | 61.68 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.03 | 0.13 | -0.1 | -0.19 | 0.25 | 0.03 | Upgrade
|
Net Cash Flow | 10.95 | 126.73 | -93.78 | -36.56 | 66.76 | 36.66 | Upgrade
|
Free Cash Flow | -104.47 | -100.43 | 9.43 | 58.59 | 84.18 | 16.14 | Upgrade
|
Free Cash Flow Growth | - | - | -83.90% | -30.40% | 421.72% | - | Upgrade
|
Free Cash Flow Margin | -19.00% | -19.72% | 1.75% | 10.95% | 17.03% | 4.59% | Upgrade
|
Free Cash Flow Per Share | -0.98 | -0.94 | 0.09 | 0.57 | 0.77 | 0.17 | Upgrade
|
Cash Interest Paid | 1.98 | 0.01 | 0.04 | 0.1 | 8.69 | 13.7 | Upgrade
|
Cash Income Tax Paid | 16.54 | 13.67 | 5.48 | 3.11 | -3.26 | 11.24 | Upgrade
|
Levered Free Cash Flow | -24.58 | -10.2 | 51.76 | 104.89 | 66.98 | 24.89 | Upgrade
|
Unlevered Free Cash Flow | -24.51 | -11.44 | 50.55 | 103.7 | 73.45 | 33.41 | Upgrade
|
Change in Net Working Capital | -2.12 | -30.43 | -9.9 | -50.03 | 15.71 | 16.62 | Upgrade
|
Source: S&P Capital IQ. Standard template.